Join
Live feed
·
PRReleasevia Quantisnow
Revelation Biosciences Inc. logo

Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study

ByQuantisnow·Wall Street's wire, on your screen.
REVB· Revelation Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REVB (Revelation Biosciences Inc.) and more on Quantisnow.